Guidance

Evidence-based recommendations on transurethral laser ablation for recurrent non-muscle-invasive bladder cancer in adults. This involves using a laser inserted into the bladder to destroy the cancer cells.

Is this guidance up to date?

Next review: July 2022

Guidance development process

How we develop NICE interventional procedures guidance

Coding and clinical classification codes for this guidance

Endorsing bodies

This interventional procedures guidance is endorsed by Healthcare Improvement Scotland as required by the Health and Social Care Act (2012).

  • National Institute for Health and Care Excellence (NICE)